Evaluating a home skin device for atopic dermatitis flares
Studies a home skin-measuring device in people with atopic dermatitis over 90 days.
Plain-language title generated from the registry record
Registry title: Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Key facts
- Where
- Caledonia, Columbus, Henderson, Las Vegas, Lee's Summit, Longview, Los Angeles, Missouri City, Morgantown, New York, Norfolk, Phoenix, Portsmouth, Rockville, South Jordan, and Tampa, United StatesSee the 16 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 89 years old?
Source: NCT07645820, who can take part
Where in United States
- Derm Research Institute, PLCCaledonia, United StatesTaking people
- AMR Clinical - Columbus, OHColumbus, United StatesTaking people
- Advanced Dermatology and Cosmetic Surgery - HendersonHenderson, United StatesTaking people
- Las Vegas DermatologyLas Vegas, United StatesTaking people
- U.S. Dermatology Partners Lee's SummitLee's Summit, United StatesTaking people
- DCOL Center for Clinical ResearchLongview, United StatesTaking people
- James Y. Wang MD, IncLos Angeles, United StatesTaking people
- Harrison DermatologyMissouri City, United StatesTaking people
- West Virginia Research InstituteMorgantown, United StatesTaking people
- The Skin Center Dermatology GroupNew York, United StatesTaking people
- Virginia Clinical Research, Inc.Norfolk, United StatesTaking people
- U.S. Dermatology PartnersPhoenix, United StatesTaking people
- StracSkin, PLLCPortsmouth, United StatesTaking people
- U.S. Dermatology Partners RockvilleRockville, United StatesTaking people
- Jordan Valley DermatologySouth Jordan, United StatesTaking people
- True Blue Clinical ResearchTampa, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Castle Biosciences Incorporated
- Trial code
- NCT07645820
- Record updated
- 9 November 2026
- Original description
This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic diary entries, and up to five in-person study visits. The study is based on the idea that changes in skin barrier function may occur before an AD flare becomes visible or symptoms begin. Information collected during the study, including device measurements, diary entries, and investigator assessments, will be used to evaluate whether these changes may help estimate the likelihood of an AD flare before visible signs or symptoms occur.Read full original descriptionShow less
Evaluation of a Non-Invasive Device for Early Detection of Flares in Adults and Adolescents With Atopic Dermatitis
This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic diary entries, and up to five in-person study visits. The study is based on the idea that changes in skin barrier function may occur before an AD flare becomes visible or symptoms begin. Information collected during the study, including device measurements, diary entries, and investigator assessments, will be used to evaluate whether these changes may help estimate the likelihood of an AD flare before visible signs or symptoms occur.
Inclusion: Participants may be eligible if they:; Are 12 to 89 years old; Have been diagnosed with atopic dermatitis (eczema); Have had at least one atopic dermatitis flare within the past 2 months; Are willing and able to use the Nevisense Go device at home, complete an electronic symptom diary, and attend study visits; If currently using systemic treatment for atopic dermatitis, have been on the same treatment for at least 3 months and do not plan to change treatment during the study.
Exclusion: Have another skin condition that may affect study assessments; Participants may not be eligible if they:; Are unwilling or unable to avoid applying creams, lotions, ointments, or soap to measurement areas for 6 hours before measurements; Do not have suitable skin areas for study measurements; Are pregnant.